Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Say goodbye to ink spills and dead pens, and hello to a future where your pen is always ready to go. It's on sale for a ...
Verywell Health on MSN12h
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data ShowsEli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback